Suppr超能文献

下丘脑-垂体-性腺轴的G蛋白偶联受体:Gnrh、LH、FSH和GPR54受体配体的情况

G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.

作者信息

Heitman Laura H, Ijzerman Adriaan P

机构信息

Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.

出版信息

Med Res Rev. 2008 Nov;28(6):975-1011. doi: 10.1002/med.20129.

Abstract

The hypothalamic-pituitary-gonadal (HPG) axis, important in reproduction and sex hormone-dependent diseases, is regulated by a number of G protein-coupled receptors. The recently "deorphanized" GPR54 receptor activated by the peptide metastin is thought to be the key regulator of the axis, mainly by releasing gonadotropin-releasing hormone (GnRH) from the hypothalamus. The latter decapeptide, through the activation of the GnRH receptor in the anterior pituitary, causes the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which subsequently activate their respective receptors on the gonadotrope cells. In this review we will discuss the small molecule agonists and antagonists that are currently being developed to intervene with the action of these four receptors. For GnRH receptors, 14 different chemical classes of non-peptidic antagonists have been reported, while for the LH receptor three classes of agonists have been described. Both agonists and antagonists have been introduced for the FSH receptor. Recently, the first non-peptidic agonist for GPR54 was reported.

摘要

下丘脑-垂体-性腺(HPG)轴在生殖及性激素依赖性疾病中至关重要,受多种G蛋白偶联受体调控。最近被“孤儿受体鉴定”的GPR54受体可被肽类metastin激活,被认为是该轴的关键调节因子,主要通过从下丘脑释放促性腺激素释放激素(GnRH)来实现。后者这种十肽通过激活垂体前叶的GnRH受体,促使黄体生成素(LH)和促卵泡激素(FSH)分泌,随后它们激活各自在促性腺激素细胞上的受体。在本综述中,我们将讨论目前正在研发的用于干预这四种受体作用的小分子激动剂和拮抗剂。对于GnRH受体,已报道了14种不同化学类别的非肽类拮抗剂,而对于LH受体,已描述了三类激动剂。FSH受体的激动剂和拮抗剂均已被引入。最近,首个GPR54的非肽类激动剂已被报道。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验